Cargando…
Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease
BACKGROUND AND AIM: Interleukin-21 (IL-21) is primarily a T cell-derived cytokine; it is upregulated in patients with Crohn's Disease (CD) and could be a potential new therapeutic target in CD. METHODS: In human material, IL-21 and IL-21R expression was investigated by in situ hybridization (IS...
Autores principales: | Holm, Thomas Lindebo, Tornehave, Ditte, Søndergaard, Henrik, Kvist, Peter Helding, Sondergaard, Bodil-Cecilie, Hansen, Lene, Hermit, Mette Brunsgaard, Holgersen, Kristine, Vergo, Sandra, Frederiksen, Klaus Stensgaard, Haase, Claus, Lundsgaard, Dorthe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914125/ https://www.ncbi.nlm.nih.gov/pubmed/29849593 http://dx.doi.org/10.1155/2018/5962624 |
Ejemplares similares
-
Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis
por: Soendergaard, Christoffer, et al.
Publicado: (2017) -
Antibody-Mediated Targeting of the Orai1 Calcium Channel Inhibits T Cell Function
por: Cox, Jennifer H., et al.
Publicado: (2013) -
Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease
por: Lindebo Holm, Thomas, et al.
Publicado: (2012) -
IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma
por: Frederiksen, Klaus Stensgaard, et al.
Publicado: (2008) -
Treatment with a Monoclonal Anti-IL-12p40 Antibody Induces Substantial Gut Microbiota Changes in an Experimental Colitis Model
por: Castro-Mejía, Josué, et al.
Publicado: (2016)